Rainer Wiewrodt

5.5k total citations
97 papers, 3.8k citations indexed

About

Rainer Wiewrodt is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Rainer Wiewrodt has authored 97 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 34 papers in Pulmonary and Respiratory Medicine and 28 papers in Molecular Biology. Recurrent topics in Rainer Wiewrodt's work include Lung Cancer Treatments and Mutations (12 papers), Peptidase Inhibition and Analysis (9 papers) and Virus-based gene therapy research (8 papers). Rainer Wiewrodt is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Peptidase Inhibition and Analysis (9 papers) and Virus-based gene therapy research (8 papers). Rainer Wiewrodt collaborates with scholars based in Germany, United States and Switzerland. Rainer Wiewrodt's co-authors include Steven Μ. Albelda, Vladimir R. Muzykantov, L. H. Schmidt, Wolfgang E. Berdel, Carsten Müller‐Tidow, Alessandro Marra, Tilmann Spieker, Michael Koval, Ludger Hillejan and Antje Hascher and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Rainer Wiewrodt

96 papers receiving 3.7k citations

Peers

Rainer Wiewrodt
Renate Kain Austria
Rainer Wiewrodt
Citations per year, relative to Rainer Wiewrodt Rainer Wiewrodt (= 1×) peers Renate Kain

Countries citing papers authored by Rainer Wiewrodt

Since Specialization
Citations

This map shows the geographic impact of Rainer Wiewrodt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rainer Wiewrodt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rainer Wiewrodt more than expected).

Fields of papers citing papers by Rainer Wiewrodt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rainer Wiewrodt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rainer Wiewrodt. The network helps show where Rainer Wiewrodt may publish in the future.

Co-authorship network of co-authors of Rainer Wiewrodt

This figure shows the co-authorship network connecting the top 25 collaborators of Rainer Wiewrodt. A scholar is included among the top collaborators of Rainer Wiewrodt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rainer Wiewrodt. Rainer Wiewrodt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fischer, Rieke, Julie George, Hans Anton Schloesser, et al.. (2024). BIOLUMA: A phase II trial of nivolumab and ipilimumab in lung cancer—Results from the SCLC TMBhigh cohort.. Journal of Clinical Oncology. 42(16_suppl). 8099–8099. 1 indexed citations
2.
Schughart, Klaus, Rainer Wiewrodt, Stefan Fischer, et al.. (2024). Molecular characterisation of influenza B virus from the 2017/18 season in primary models of the human lung reveals improved adaptation to the lower respiratory tract. Emerging Microbes & Infections. 13(1). 2402868–2402868. 1 indexed citations
3.
Troschel, Fabian M., et al.. (2023). Cervical body composition on radiotherapy planning computed tomography scans predicts overall survival in glioblastoma patients. Clinical and Translational Radiation Oncology. 40. 100621–100621. 3 indexed citations
4.
Müther, Michael, Ralf Brandt, Walter Stummer, et al.. (2023). Conceptual development of an intensive exercise program for glioma patients (ActiNO): summary of clinical experience. Journal of Neuro-Oncology. 163(2). 367–376. 2 indexed citations
5.
Evers, Georg, Arik Bernard Schulze, Irina Osiaevi, et al.. (2022). Sustained Impairment in Cardiopulmonary Exercise Capacity Testing in Patients after COVID-19: A Single Center Experience. Canadian Respiratory Journal. 2022. 1–11. 15 indexed citations
6.
Schloer, Sebastian, Rainer Wiewrodt, Karsten Wiebe, et al.. (2022). 3D Ex vivo tissue platforms to investigate the early phases of influenza a virus- and SARS-CoV-2-induced respiratory diseases. Emerging Microbes & Infections. 11(1). 2160–2175. 6 indexed citations
8.
Schnabel, Philipp A., Rainer M. Bohle, Rainer Wiewrodt, et al.. (2017). Nontypeable Haemophilus influenzae–Promoted Proliferation of Kras-Induced Early Adenomatous Lesions Is Completely Dependent on Toll-Like Receptor Signaling. American Journal Of Pathology. 187(5). 973–979. 13 indexed citations
10.
Hascher, Antje, Katja Hebestreit, Christian Rohde, et al.. (2013). DNA Methyltransferase Inhibition Reverses Epigenetically Embedded Phenotypes in Lung Cancer Preferentially Affecting Polycomb Target Genes. Clinical Cancer Research. 20(4). 814–826. 41 indexed citations
11.
Beißwenger, Christoph, Christian Herr, Gang Han, et al.. (2013). Myeloid cell RelA/p65 promotes lung cancer proliferation through Wnt/β-catenin signaling in murine and human tumor cells. Oncogene. 33(10). 1239–1248. 53 indexed citations
12.
Dirksen, Uta, et al.. (2010). Pulmonary dirofilariasis in a Caucasian patient with metastasised osteosarcoma in a non-endemic European region. Thorax. 66(3). 270–270. 3 indexed citations
13.
Maxeiner, Joachim, Petra Scholtes, Michael Koslowski, et al.. (2009). A Key Regulatory Role of the Transcription Factor NFATc2 in Bronchial Adenocarcinoma via CD8+ T Lymphocytes. Cancer Research. 69(7). 3069–3076. 16 indexed citations
14.
Sebastian, Martin, Philipp Kiewe, Wolfgang Schuette, et al.. (2009). Treatment of Malignant Pleural Effusion With the Trifunctional Antibody Catumaxomab (Removab) (Anti-EpCAM×Anti-CD3). Journal of Immunotherapy. 32(2). 195–202. 44 indexed citations
15.
Hoffarth, S, Alexander Zitzer, Rainer Wiewrodt, et al.. (2007). pp32/PHAPI determines the apoptosis response of non-small-cell lung cancer. Cell Death and Differentiation. 15(1). 161–170. 39 indexed citations
16.
Singhal, Sunil, Rainer Wiewrodt, Kunjlata M. Amin, et al.. (2003). Gene expression profiling of malignant mesothelioma.. PubMed. 9(8). 3080–97. 107 indexed citations
17.
Christofidou‐Solomidou, Melpo, Arnaud Scherpereel, Rainer Wiewrodt, et al.. (2003). PECAM-directed delivery of catalase to endothelium protects against pulmonary vascular oxidative stress. American Journal of Physiology-Lung Cellular and Molecular Physiology. 285(2). L283–L292. 77 indexed citations
18.
Christofidou‐Solomidou, Melpo, Stephen J. Kennel, Arnaud Scherpereel, et al.. (2002). Vascular Immunotargeting of Glucose Oxidase to the Endothelial Antigens Induces Distinct Forms of Oxidant Acute Lung Injury. American Journal Of Pathology. 160(3). 1155–1169. 46 indexed citations
19.
20.
Merget, R., et al.. (1993). Diagnostic tests in enzyme allergy. Journal of Allergy and Clinical Immunology. 92(2). 264–277. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026